KIMSKrishna Institute of Medical Sciences Ltd
Revenue surges 35%, profit plunges 56%—the new-unit reckoning
margin compression · new unit ramp · PAT cliff
Research Reports
16 Aug 2026
KIMSKrishna Institute of Medical Sciences Ltd
Volume boom masks 56% PAT cliff; new units ramp, execution risks linger
new unit ramp · margin pressure · debt reduction
ASTERDMAster DM Healthcare Ltd
Revenue surge masks profit collapse as merger integration costs hit
merger-integration · synergies-pending · margin-compression
ASTERDMAster DM Healthcare Ltd
Revenue +21.6%, but PAT crashed 68.7% due to ₹114Cr merger costs
merger-integration · synergies-pending · margin-compression
SANOFISanofi India Ltd
Diabetes roars, partnerships stall—and the street is unconvinced
diabetes franchise · public sector expansion · partnership drag
SANOFISanofi India Ltd
Diabetes surge offset by partnership drag; margins intact but outlook hedged
diabetes leadership · public sector expansion · partnership volatility
MEDANTAGlobal Health Ltd
Volume boom, profit stuck — and management won't say when that changes
margin compression · Noida ramp-up · greenfield execution
MEDANTAGlobal Health Ltd
Strong volume growth masks margin pressure; Noida ahead of plan
volume growth · Noida ramp-up · margin compression
NHNarayana Hrudayalaya Ltd
78% revenue growth, 5% profit—the integrated care thesis works, but it's not profitable yet
integrated care model · margin compression · insurance losses
NHNarayana Hrudayalaya Ltd
Revenue 78% YoY but profit +5%—margin compression masks growth momentum
integrated care model · margin expansion · insurance losses
FORTISFORTIS HEALTHCARE LTD.
17.5% Revenue Growth Can't Mask 2.3% Profit Growth — Margin Compression and Guidance Delays
margin compression · PAT growth lag · ESOP charge
FORTISFORTIS HEALTHCARE LTD.
Strong revenue growth masked by margin compression and guidance delays
ESOP alignment · new unit ramp-up · oncology pricing headwind
GLAXOGLAXOSMITHKLINE PHARMACEUTICALS LTD.
Strong YoY growth masks Q1 sequential weakness; innovation pipeline credible but early-stage
portfolio transformation · innovation 7% · Shingrix 65%
EMCUREEmcure Pharmaceuticals Ltd
The 22.8% beat nobody's betting on
revenue beat · domestic organic soft · guidance caution
EMCUREEmcure Pharmaceuticals Ltd
Revenue beat masked by soft domestic organic and maintained cautious guidance
revenue beat · domestic organic soft · ARV ramp
LUPINLUPIN LTD.
Beat growth, margin pressure starts
earnings · growth · margin compression
LUPINLUPIN LTD.
Record Q1 growth masks margin compression ahead
US competition pressure · pipeline execution · margin normalization
DIVISLABDIVI'S LABORATORIES LTD.
₹902 Crore Profit Masks Flat Generic Volumes and Margin Lumpiness
CDMO · Custom Synthesis · capex ramp
DIVISLABDIVI'S LABORATORIES LTD.
27.8% growth masks generic stagnation; capex ramp ahead
custom synthesis ramp · validation batches · regulatory dependency
MANIPALHOSManipal Health Enterprises Ltd
Can Manipal Health Sustain Q1 Momentum with Bed Expansion & Occupancy Gains?
bed capacity expansion · occupancy rates · ARPOB trajectory
15 Aug 2026
14 Aug 2026
DCALDishman Carbogen Amcis Ltd
Dishman Carbogen swings to Rs57.9 Cr consolidated loss as margins crash to 8.9% YoY
cdmo · pharma api · margin compression
GUFICBIOGUFIC BIOSCIENCES LTD.
Gufic Biosciences Q1FY27: consolidated PAT +71% YoY on margin gains, revenue +16.6%
pharmaceuticals · margin expansion · yoy growth
GKSLGujarat Kidney and Super Speciality Ltd
Gujarat Kidney Q1: consolidated PAT flat YoY despite 125% revenue surge as margins halve
hospital chain · margin compression · consolidated results
RUBICONRubicon Research Ltd
Rubicon Q1FY27: consolidated PAT up 96% YoY to ₹84.8 Cr, margin beats 22-23% guidance
pharmaceuticals · cdmo · margin expansion
METROPOLISMetropolis Healthcare Ltd
When Smart Money Exits in Sync: Metropolis's Coordinated Institutional & Promoter Sell-Off
insider selling · institutional exit · shareholding pattern
ResearchDeep dive7 minPharma & Healthcare
NATCOPHARMNATCO PHARMA LTD.
Natco Q1 FY27: consolidated PAT falls 57% YoY to ₹206.5 Cr on Lenalidomide exit
lenalidomide · margin compression · yoy decline
ALKEMAlkem Laboratories Ltd
Alkem Q1FY27: consolidated PAT down 22% YoY on tax-regime reset, PBT nearly flat
pharma · tax regime change · effective tax rate
KMCSHILKMC SPECIALITY HOSPITALS (INDIA) LTD.
KMC Speciality Hospitals Q1 FY27: PAT surges 120% YoY as margins expand, revenue +38%
hospital · healthcare services · margin expansion
THYROCAREThyrocare Technologies Ltd
When the Promoter Steps Back—Thyrocare's ₹977 Crore Exit Decoded
promoter exit · shareholding · deleveraging
ResearchCatalyst check6 minPharma & Healthcare